Clene Nanomedicine Email Format

Pharmaceutical ManufacturingUtah, United States51-200 Employees

Clene Nanomedicine, Inc. is a mid-sized biopharmaceutical company focused on neurodegenerative diseases and mitochondrial health. Its lead asset, CNM-Au8, is an investigational therapy designed to enhance central nervous system cell survival and function by targeting mitochondrial processes and the NAD pathway while reducing oxidative stress. The company is based in Salt Lake City, Utah, with research and manufacturing activities located in Maryland.

Its patient focus includes individuals affected by amyotrophic lateral sclerosis, Parkinson's disease, and multiple sclerosis. In May 2026, Clene announced plans to participate in multiple investor events, reflecting ongoing engagement with the research and investment community during its late-stage development.

Sign up for free to view info

Company overview Employee directory